Jonas A. Nilsson
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- Extracellular vesicles in disease
- Ubiquitin and proteasome pathways
- RNA Interference and Gene Delivery
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
Papers in
-
- Ocular Oncology and Treatments 16
- Oncology 41
- CAR-T cell therapy research 13
- Cancer-related Molecular Pathways 12
- Cancer Immunotherapy and Biomarkers 12
- Co-authors
- John L. ClevelandLisa M. NilssonErik LarssonMartin O. BergöPer LindahlVolkan I. SayinMohamed X. IbrahimUlrich Keller
- Journals
- Cancers (5 papers)Cancer Research (5 papers)Journal of Clinical Oncology (5 papers)Oncogene (4 papers)Oncotarget (4 papers)
- Partner nations
- SwedenUnited StatesAustralia
In The Last Decade
Jonas A. Nilsson
106 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 2.1k
- Molecular Biology 5.5k
- Oncology 2.0k
- Immunology 1.5k
- Ophthalmology 327
Countries citing papers authored by Jonas A. Nilsson
This map shows the geographic impact of Jonas A. Nilsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas A. Nilsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas A. Nilsson more than expected).
Fields of papers citing papers by Jonas A. Nilsson
This network shows the impact of papers produced by Jonas A. Nilsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas A. Nilsson. The network helps show where Jonas A. Nilsson may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonas A. Nilsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 33 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 15 | |
| 8 | 2020 | 4 | |
| 9 | 2019 | 133 | |
| 10 | 2019 | 52 | |
| 11 | 2017 | 15 | |
| 12 | 2017 | 98 | |
| 13 | 2016 | 14 | |
| 14 | 2015 | 78 | |
| 15 | 2011 | 110 | |
| 16 | 2010 | 45 | |
| 17 | 2010 | 26 | |
| 18 | 2007 | 81 | |
| 19 | 2006 | 24 | |
| 20 | 2005 | 38 |
About Jonas A. Nilsson
Jonas A. Nilsson is a scholar working on Ophthalmology, Oncology, Immunology, Cancer Research and Molecular Biology, having authored 110 papers that have together received 7.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (21 papers), Ocular Oncology and Treatments (16 papers), CAR-T cell therapy research (13 papers), Cancer-related Molecular Pathways (12 papers), Cancer Immunotherapy and Biomarkers (12 papers), Histone Deacetylase Inhibitors Research (9 papers), Epigenetics and DNA Methylation (8 papers) and Protein Degradation and Inhibitors (8 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (5.5k citations), Oncology (2.0k citations), Immunology (1.5k citations) and Ophthalmology (327 citations). Jonas A. Nilsson has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include John L. Cleveland, Lisa M. Nilsson, Erik Larsson, Martin O. Bergö, Per Lindahl, Volkan I. Sayin, Mohamed X. Ibrahim, Ulrich Keller, Jan Lötvall and Yong Song Gho. Their work appears in journals such as Cancers, Cancer Research, Journal of Clinical Oncology, Oncogene and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.